Speciality: Anesthesia
Description:
Before any surgery, a pre-anesthesia evaluation is a crucial step that helps ensure your safety. This assessment allows anaesthetists to review your medical history, current medications, and allergies, as well as to evaluate your overall health. By identifying potential risks or complications ahead of time, the anaesthesia team can tailor their approach specifically to your needs. This process also gives you the opportunity to ask questions and understand what to expect before, during, and after your procedure. Ultimately, a thorough pre-anesthesia evaluation minimises risks, improves outcomes, and provides peace of mind for both patients and clinicians. Remember, your safety starts well before you enter the operating theatre.
See More Webinars @ Hidoc Webinars
1.
Microplastics can cause malignant changes in lung cells
2.
New target points to combination therapy for thwarting multidrug resistance in cancer treatment
3.
New research demonstrates a method for screening people at high risk for pancreatic cancer.
4.
Rural residents continue to have higher odds of skin cancer, study finds
5.
Survival improved with lobectomy, segmentectomy in early non-small cell lung cancer
1.
Hematopoietic Stem Cell Clonal Dynamics Across the Lifespan
2.
Uncovering the Hidden Gallons: How Much Blood Is Inside the Human Body?
3.
Innovative Approaches in Oncology for Modern Medicine
4.
Therapeutic Innovations Through Germline Predisposition in Acute Leukemias and Myeloid Neoplasms
5.
Inside Oncology Trials: From Protocol to Progress in Cancer Research and Care
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Understanding the Role of Screening in Cancer Prevention
2.
From Guidelines to Practice: Hematology
3.
Efficient Management of First line ALK-rearranged NSCLC - Part VII
4.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part III
5.
Navigating the Complexities of Ph Negative ALL - Part VI
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation